Does Endometriosis Affect Embryo Implantation?
If the egg is good and the embryo is good, why wouldn't it stick? Endometriosis has a possible answer — and the evidence has a surprising twist.
Short answer. Possibly — but less than the egg does. The theory holds that endometriosis-driven inflammation and altered lining gene expression could reduce receptivity. Yet the most telling evidence points elsewhere: donor-egg studies, where women with endometriosis receive eggs from unaffected donors, show largely normal implantation — suggesting the egg carries more of the effect than the uterus. The practical exception worth checking is adenomyosis, a distinct condition that more directly affects implantation.
The receptivity theory — what it proposes
The uterine lining must be biochemically ready to accept an embryo within a narrow window, and endometriosis could in theory disturb that readiness: pelvic inflammation, altered immune signaling, and differences in the lining's gene expression have all been proposed as ways the disease might make implantation less likely. It is a coherent hypothesis, and it feeds real anxiety in women facing repeated IVF. But within honest endometriosis care, a coherent hypothesis is a starting point for evidence, not a substitute for it — and here the evidence takes an instructive turn.
Source: ESHRE — endometriosis guideline: endometrial receptivity.
Why donor-egg data reframe the question
The cleanest natural experiment separates the egg's contribution from the uterus's — and its answer is clarifying.
| Observation | What it implies |
|---|---|
| Women with endometriosis using donor eggs implant largely normally | The uterus is more capable than the receptivity theory feared |
| The same women using their own eggs may do less well | Points the effect back toward the egg, not the lining |
| Recipient uterus performs regardless of donor's status | Receptivity is often preserved in endometriosis |
| Adenomyosis breaks this pattern | A distinct uterine condition with its own implantation effect |
Learn more: Does Endometriosis Affect Egg Quality?
Source: ASRM — endometriosis and implantation.
The adenomyosis exception — worth checking
Endometriosis's close relative deserves separate attention here. Adenomyosis — endometrial-type tissue within the uterine muscle itself — affects the uterus directly, and it is more consistently linked to reduced implantation and higher miscarriage risk than endometriosis is. The two conditions frequently coexist, and a woman told her repeated implantation failures are "because of endometriosis" may actually have an unrecognized adenomyosis component driving the uterine part of the problem. This is why a receptivity work-up in this setting looks specifically for adenomyosis rather than blaming endometriosis in general — the distinction can change both the explanation and the plan.
| Condition | Its implantation relationship |
|---|---|
| Endometriosis (lesions outside the uterus) | Effect on receptivity appears modest; egg matters more |
| Adenomyosis (tissue in the uterine muscle) | More directly linked to implantation and miscarriage |
| Both together | Common — and worth distinguishing, since they act differently |
Patients also ask: Adenomyosis vs Endometriosis — Differences and Can You Have Both?
At our clinic in Türkiye, when implantation keeps failing we look specifically for adenomyosis rather than blaming endometriosis in general — the uterine story is often a different one than the pelvic story.
Second opinion. If repeated implantation failure has been attributed to endometriosis without adenomyosis being assessed, an independent review may reframe it; you can request an online second opinion for endometriosis.
How much adenomyosis actually changes
The exception deserves its numbers. Adenomyosis is associated with implantation rates reduced by roughly a third and miscarriage rates approximately doubled in IVF series — effects considerably more consistent than anything attributed to endometriosis lesions outside the uterus. It coexists with endometriosis in a large share of women, with figures above 20-40% reported depending on how carefully it is sought. And it is frequently missed, because it requires someone to look for it specifically on ultrasound or MRI rather than noting the endometriosis and stopping there.
What a receptivity work-up should actually cover
Before accepting "endometriosis" as the explanation for repeated implantation failure, several checkable things deserve exclusion. Adenomyosis, assessed by expert transvaginal ultrasound or MRI. Structural uterine findings — polyps, submucous fibroids, adhesions — which hysteroscopy identifies and often treats in the same session. A hydrosalpinx, whose fluid halves implantation and is correctable. Thyroid function and other systemic contributors. Endometrial receptivity testing exists but remains debated and is not routine. The productive sequence checks the treatable structural causes first.
What can be done when a uterine factor is found
Finding something is usually good news, because most of these findings are addressable. Adenomyosis is commonly managed with several months of hormonal suppression before transfer, an approach with reasonable support for improving outcomes. Polyps, submucous fibroids and intrauterine adhesions are removed hysteroscopically. A hydrosalpinx is clipped or removed before the cycle. Where no uterine factor emerges, attention returns to the embryo — genetic testing, embryo accumulation, protocol change — which is the appropriate destination rather than the starting assumption.
Frequently Asked Questions
Embryo grading under a microscope predicts genetic normality imperfectly, so appearance alone does not guarantee viability. Beyond that, a uterine factor such as adenomyosis, a polyp or a hydrosalpinx may be present and checkable.
It exists, but remains debated and is not routine. Checking the treatable structural causes first — adenomyosis, polyps, fibroids, hydrosalpinx — has better evidence and often better yield.
By expert transvaginal ultrasound or MRI looking specifically for its features in the uterine wall. It is frequently missed simply because nobody looked, which is why asking directly is worthwhile after repeated failures.
Commonly with several months of hormonal suppression before the transfer, which has reasonable support for improving outcomes. Surgical options exist for focal disease but are considered case by case.
There is little evidence that removing pelvic lesions improves endometrial receptivity, so it is not performed for that reason. Surgery for a hydrosalpinx is the clear exception, and it works through a different mechanism.
Many teams investigate after two or three failed transfers of good-quality embryos. With significant endometriosis or suspected adenomyosis, raising the question earlier is reasonable — the checks are simple and the findings often treatable.
When implantation keeps failing, the reflex is to blame the endometriosis in the pelvis. But the donor-egg data quietly point at the egg, and the uterus that fails is often failing from adenomyosis, not endometriosis. Naming the right culprit is half the treatment.
